Jeffrey Laurence

Austrian Research Institute for Artificial Intelligence — Austria

Immunology and Microbiology · Life Sciences

46h-index7.9kcitations348works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(79), HIV/AIDS Research and Interventions(76), Complement system in diseases(50), HIV/AIDS drug development and treatment(40), HIV/AIDS Impact and Responses(29)

Publications348 total

Publisher Correction: Academia Europaea’s guidelines for the visualization of clinical outcomes
Nature Medicine·2025Open Access
Academia Europaea’s guidelines for the visualization of clinical outcomes
Nature Medicine·2025
Protecting the Dolls: HIV Risk Among Transgender Women as LGBTQ+ Rights and Global HIV Prevention Strategies Engage New Politics
AIDS Patient Care and STDs·2025
Atorvastatin suppresses cardiac fibrosis and dysfunction induced by HIV and certain antiretroviral drugs in mice by blocking platelet TGFβ1
2025Open Access
Long COVID Patient Plasmas Induce Endothelial Cell Injury via the Lectin Complement Pathway: In Vitro Data and Clinical Correlations
SSRN Electronic Journal·2025Open Access
Treatment discontinuation in adults with atypical hemolytic uremic syndrome (aHUS): a qualitative study of international experts’ perspectives with associated cost-consequence analysis
BMC Nephrology·2024· 5 citedOpen Access
Refining the standard of care in immune thrombotic thrombocytopenic purpura.
PubMed·2024· 2 cited
“AIDS at a Crossroads:” Highlights from the 2024 UNAIDS Report
AIDS Patient Care and STDs·2024· 5 cited
Following the Money: Level of Co-Payment Directly Impacts HIV PrEP Utilization
AIDS Patient Care and STDs·2024· 2 cited
Treatment discontinuation in atypical hemolytic uremic syndrome (aHUS): A qualitative study of international experts’ perspectives with associated cost-consequence analysis
2024Open Access
“The Path That Ends AIDS”: National and International Politics in Conflict with Treatment and Prevention Science
AIDS Patient Care and STDs·2023· 4 cited
Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation
Bone Marrow Transplantation·2023· 3 cited
MASP2 inhibition by narsoplimab suppresses endotheliopathies characteristic of transplant-associated thrombotic microangiopathy:<i>in vitro</i>and<i>ex vivo</i>evidence
Clinical & Experimental Immunology·2023· 9 citedOpen Access
Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies
Thrombosis Research·2023· 7 citedOpen Access
Distinct inflammatory profiles linked to cardiovascular disease risk in HIV infection: implications for the design of preventive and therapeutic interventions
AIDS·2023· 1 cited
The Recent Rise in Sexually Transmitted Infections in the United States Was a Harbinger of the New Monkeypox Pandemic
AIDS Patient Care and STDs·2022· 12 cited
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
Journal of Clinical Investigation·2022· 120 citedOpen Access
Table of Contents
American Journal Of Pathology·2022Open Access
Atypical hemolytic uremic syndrome after myomectomy: A case report
Case Reports in Women s Health·2022· 3 citedOpen Access
C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy
Bone Marrow Transplantation·2022· 13 cited
page 1 of 18Next →

Frequent Co-authors

Cynthia M. Magro(7), Debashis Mitra(7), John Chapin(5), J. Justin Mulvey(4), Jasimuddin Ahamed(4), Joanna Harp(3), Babette B. Weksler(3), Melissa G. Steiner(3), Lisa Staiano‐Coico(3), S K Sikder(3), Gerard J. Nuovo(2), J. Mohamad Fakruddin(2), A. Neil Crowson(2), David H. Lynch(2), Frederick P. Siegal(2), Clarinda MacLow(2), Michael T. Yin(2), H Cooke(2), David Berlin(1), Steven Salvatore(1)